This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

China's Mid-Caps Set for Earnings Season

Mid-cap China stocks have historically been quite volatile during and after the earnings season. More often than not, these stocks have been driven by market sentiment that overrides underlying fundamentals .

Here we preview some of the more prominent China stocks that are due to report earnings and that we believe present opportunistic trading ideas for investors.

Our picks include Chinese Internet stocks , which despite a reasonable outlook, have witnessed selling pressure this month. (NTES - Get Report), eLong (LONG - Get Report) and Global Sources (GSOL - Get Report) are expected to report earnings over the next two days. The stocks are currently trading at $32.15, $11.50, and $6.88, and were down 3.31%, 3.36%, and 5.23%, respectively on Monday.

China's Former Richest Man Goes to Slammer (Forbes)

There have been concerns over new regulations impacting online gaming firms in China. This, coupled with high investor expectations on new content releases, has led to a sharp correction in stock prices. However, we note that has one of the highest operating margins in the industry and the rumored partnership with Microsoft (MSFT) could help the company export its games to the U.S. and Europe.

Another Internet stock AsiaInfo Holdings (ASIA) went into a tailspin for apparently no fundamental reasons during and following its earnings announcement earlier this month. Subsequently, the stock recovered after Goldman Sachs upgraded the stock to a buy and added it to its Conviction Buy list with a $31 price target.

China's advertising major Focus Media Holding (FMCN), which reports on May 20, was down 5.29% to $15.74 on Monday. Following the recent sharp correction, we reckon the stock is undervalued. Advertising revenue is witnessing a revival across the world in conjunction with the economic recovery. Deutsche Bank recently issued an update on the stock maintaining its buy rating with a $19.36 price target.

Sina (SINA - Get Report), the largest online portal in China, announced above consensus earnings Monday and issued an upbeat outlook. The company's shares were up 3.3% in after-market trades.

In the pharmaceutical space, Simcere Pharmaceutical (SCR) is due to report earnings Tuesday. After having corrected significantly over the past three months, the stock gained over the past couple of days following news reports of a potential sale of its over-the-counter drug division, which accounts for 10% of revenue. Chief Scientific Officer Peng Wang told mergermarket the company had hired Merrill Lynch as a financial advisor. The company is also seen as an attractive takeover target for global pharmaceutical giants, although Chief Financial Officer Frank Zhao denied the possibility of a total sellout, the Financial Times reports. The stock closed at $8.06, up 0.62% on Monday.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
KONG $0.00 0.00%
ASIA $11.99 0.25%
GSOL $8.68 -1.70%
LONG $17.60 0.00%
NTES $134.88 1.31%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs